Skip to main content
Wiley Open Access Collection logoLink to Wiley Open Access Collection
. 2026 Apr 14;22(33):e73339. doi: 10.1002/smll.73339

Quantifying Population Reversibility of Sensor Performance in Multi‐Cycle Single‐Sensor Recovery Assay

Geffen Rosenberg 1, Gili Bisker 1,2,3,4,5,6,✉
PMCID: PMC13262247  PMID: 41979109

ABSTRACT

Quantitative chemical imaging requires sensors that reliably recover across repeated exposures. While solution‐phase bulk measurements provide an averaged response of the sensor population, imaging at the single‐sensor level enables mapping of biological processes with spatiotemporal resolution, revealing localized events and interaction sites. To translate such imaging into calibrated measurements, sensor variability across repeated analyte exposures must be analyzed. This work introduces a generic workflow that combines an automated microfluidic flow imaging platform with systematic characterization of the response, recovery, and reversibility of individual nanosensors under multi‐cycle challenges. For representative implementation, three near‐infrared fluorescent single‐walled carbon nanotube (SWCNT) sensor models are tested, each with a distinct functionalization rendering it optically responsive to a corresponding exemplar target: dopamine, thiocholine, or serotonin. While first‐cycle responses averaged over the entire field of view recapitulate ensemble calibration, single‐sensor analysis uncovers broad heterogeneity in response magnitude, signal recovery, and reversibility across hundreds of individual SWCNTs under repeated exposure and wash cycles. To compare performance across cycles, a standardized Population Reversibility Score based on Kullback‐Leibler Divergence is introduced, condensing response distributions into a single cycle‐ and concentration‐dependent, quantitative metric. This framework is generally applicable to other sensor‐analyte systems with transient readouts, guiding optimization for spatiotemporal analyte mapping.

Keywords: fluorescence sensors, near‐infrared, sensor recovery, sensor reversibility, single‐walled carbon nanotubes, spatiotemporal sensors


Single‐walled carbon nanotubes (SWCNTs) are versatile optical nanosensors that can be imaged at the single‐sensor level to map biological processes. To translate such imaging into calibrated measurements, sensor recovery under repeated analyte exposures must be analyzed. This work introduces a multi‐cycle assay and a Population Reversibility Score to systematically characterize the reversibility of sensor populations.

graphic file with name SMLL-22-e73339-g001.jpg

1. Introduction

Monitoring chemical messengers in living systems requires sensors that are not only sensitive and selective but also capable of providing spatiotemporal information on the presence of these messenger biomolecules [1, 2]. From synaptic neurotransmission to paracrine signaling and oxidative bursts, these events are transient, localized, and repeated, favoring imaging‐based readouts with cellular and subcellular resolution over conventional ensemble assays [3, 4, 5]. In such cases, sensors must report reliably across many exposure‐wash cycles, so that quantitative maps of concentration and dynamics can be trusted over time [6, 7]. Given single‐sensor heterogeneity and incomplete recovery after repeated challenges, there is a need for standardized metrics to compare reversibility across constructs, doses, and experimental conditions.

Within this context, single‐walled carbon nanotubes (SWCNTs) have emerged as a powerful optical sensing platform, capable of detecting and continuously monitoring a variety of target analytes. Structurally, a SWCNT can be considered a rolled‐up single‐layer graphene sheet, with a diameter of approximately 1–2 nm and varying lengths reaching up to hundreds of micrometers [8, 9, 10]. The roll‐up vector of the graphene sheet defines the SWCNT's chirality, which in turn determines the SWCNT's electronic band structure and thus its optical and fluorescence properties [8, 9, 11]. Semiconducting SWCNTs fluoresce in the near‐infrared (NIR) range, between 900 and 1400 nm [12, 13], which coincides with the optical transparency window for biological samples. This overlap enables high signal‐to‐noise ratio imaging, as it benefits from reduced background autofluorescence, absorption, and scattering [14, 15, 16]. Combined with their stable fluorescence, which does not suffer from photobleaching or blinking [17, 18], and their biocompatibility when appropriately functionalized [19, 20, 21, 22, 23, 24], SWCNTs are highly attractive as optical nanosensors [17, 25, 26, 27, 28]. Analyte recognition and signal transduction arise from the surface functionalization of the SWCNTs [29, 30, 31]. By suspending pristine or defect‐induced [32, 33, 34, 35, 36, 37] SWCNTs with different polymers [38, 39, 40, 41], peptides [42, 43, 44, 45], or DNA [46, 47, 48, 49], the corona chemistry mediates specific interactions with target analytes, leading to a detectable modulation of the emitted SWCNT fluorescence [21, 50, 51]. This approach has yielded SWCNT sensors for a wide variety of analytes, including proteins [38, 39, 52, 53, 54, 55], enzymes [41, 46, 56, 57, 58, 59], neurotransmitters [47, 48, 60, 61, 62, 63, 64, 65], and hormones [40, 66, 67].

Traditionally, SWCNT sensing studies quantify ensemble fluorescence responses in aqueous solutions, averaging over large, heterogeneous sensor populations [68]. However, the nanoscale dimensions of SWCNT also enable single‐sensor imaging with exceptional spatiotemporal resolution for detecting analyte presence. Recent work has leveraged this capability to monitor plant health [69, 70, 71], track reactive oxygen species in photoaged skin cells [72], visualize neurotransmitter release in neuronal systems [62, 66, 73, 74, 75, 76, 77, 78, 79, 80], and probe the gastrointestinal tract within C. elegans worms [81]. For example, Lee et al. embedded dopamine (DA) sensors around differentiating human induced pluripotent stem cells (hiPSC)‐derived dopaminergic neurons and, with ∼200 ms temporal and micrometer spatial resolution, mapped release “hotspots”, revealing the differences in DA release between healthy and GBA1‐mutant neurons across differentiation stages [77]. Mun et al. developed an oxytocin sensor and imaged stimulus‐evoked release in acute brain slices with ∼250 ms resolution, enabling regional comparisons of hotspot number and amplitude [66]. Moreover, Dinarvand et al. demonstrated SWCNT‐based serotonin sensors that enabled real‐time, sensitive spatiotemporal imaging of serotonin release from individual human platelets, revealing localized secretion hotspots and dynamic release kinetics at subcellular resolution [62]. In practice, the same SWCNT endures multiple analyte exposures, so quantitative readouts require reversibility, recovery, and consistent response. While reversibility has been shown qualitatively for several SWCNT sensor constructs, a quantitative analysis of single‐sensor recovery across repeated challenges is lacking. Moreover, without explicit characterization of single‐sensor performance heterogeneity, ensemble‐based calibration and measurement can misrepresent local sensing behavior during high‐resolution imaging.

Here, we address these gaps by systematically characterizing response distributions and multi‐cycle reversibility of individual SWCNTs in a controlled microfluidic platform. We study three known single‐strand DNA (ssDNA)‐functionalized SWCNT‐analyte pairs, targeting dopamine (DA) [47], thiocholine (TCh) [46], and serotonin (5‐HT) [48]. Using automated flow control and NIR imaging, we compare first‐cycle immobilized sensor responses to bulk calibrations, investigate sensor‐to‐sensor heterogeneity across hundreds of regions of interest, and track recovery over repeated exposure‐wash cycles across a wide range of analyte concentrations within the sensors’ dynamic range. To standardize comparisons across cycles and concentrations, we introduce a cycle‐ and concentration‐dependent Population Reversibility Score based on the Kullback–Leibler divergence, also known as relative entropy, which quantifies the distinguishability between two probability distributions. In our context, we measure the deviation of each cycle's response from its first‐cycle reference, thus condensing the statistical differences in response distributions of heterogeneous SWCNT populations into a single metric of reversibility. Our Reversibility Score elucidates the effects of analyte polymerization, incomplete washout, and potential corona modifications, thereby establishing design and analysis principles for reliable, quantitative single‐sensor high‐resolution imaging with nanosensors.

2. Results

2.1. Initial Bulk Characterization of SWCNT Sensor Response

HipCO SWCNTs were suspended with single‐strand DNA (ssDNA) corona, DNA1, DNA2, and DNA3 (see the full sequences in the Experimental Section), to render them optically responsive to Dopamine (DA) [47], thiocholine (TCh) [46], and serotonin (5‐HT) [48], respectively. The DNA1‐SWCNT sensor for DA was discovered via corona phase molecular recognition screening of polymer‐wrapped SWCNTs, where DNA1 ssDNA emerged as a lead corona that yields a significant turn‐on fluorescence response to dopamine with high sensitivity, attributed to dopamine‐induced conformational changes in the DNA corona that increase the SWCNT's fluorescence quantum yield [47]. DNA2‐SWCNT was identified via a DNA‐SWCNT library screen for cholinesterase (ChE) activity, in which DNA2‐SWCNTs showed a strong, selective fluorescence increase in response to thiocholine, the enzymatic hydrolysis product of acetylthiocholine, with negligible responses to the enzyme or substrate alone, establishing DNA2‐SWCNTs as a reporter of ChE activity and inhibition [46]. DNA3‐SWCNT was found through machine learning models trained on spectral data sets of numerous DNA‐SWCNT conjugates to predict high‐response candidates, which yielded several ssDNA‐SWCNTs, including DNA3, predicted to exhibit a strong fluorescence response to 5‐HT [48]. In experimental validation, DNA3‐SWCNT showed the strongest response to 5‐HT and was therefore selected for our study.

Successful functionalization was confirmed by the distinguishable peaks of the different SWCNTs chiralities in the absorption spectra (Figure S1) and in the excitation‐emission maps of their NIR‐fluorescence (Figure S2). Subsequently, the fluorescence responses of the suspensions to different concentrations of the corresponding analytes were recorded (Figure S3), showing an increase in fluorescence intensity with increasing analyte concentrations for all analytes tested. For DNA1‐SWCNT, the response reached saturation at ∼50 µm DA, but declined above 100 µm DA, likely due to DA polymerization [47, 82]. The peak fluorescence values of the (8,6), (9,4), and (10,2) chiralities in response to different analyte concentrations were extracted via deconvolution using Lorentzian functions. The normalized SWCNT fluorescence responses of the chirality peaks were fitted using the Hill isothermal model [83] (Figure S4):

I−I0I0=βCnCn+Kn (1)

where I 0 and I are the fluorescence intensities before and after analyte addition, respectively, C is the analyte concentration in the solution, K is the analyte concentration producing 50% of the maximal fluorescence response, n is the Hill coefficient, and β is a proportionality factor (Table S1). As shown in Table S1, these parameters vary across SWCNT chiralities, reflecting chirality‐dependent sensitivity and response profiles. While single‐chirality samples can provide a refined spectroscopic readout, our subsequent reversibility analysis captures the collective behavior of the mixed‐chirality ensemble. Importantly, the analysis framework itself is not limited to heterogeneous populations and can be applied equally to single‐chirality suspensions, where it would quantify reversibility at the level of that specific sensor species.

The K constant for the (9,4) chirality, for example, was found to be 842 nM, 13.58 µM, and 1.622 µM for DA with DNA1‐SWCNT, TCh with DNA2‐SWCNT, and 5‐HT with DNA3‐SWCNT, respectively. The limit of detection (LOD) was calculated according to the calibration fit as the analyte concentration at which the Hill function fit equals three times the standard deviation of the DNA‐SWCNT intensity without the analyte, and was found to be for the (9,4) chirality 13, 12, and 582 nm for DA with DNA1‐SWCNT, TCh with DNA2‐SWCNT, and 5‐HT with DNA3‐SWCNT, respectively. Compared with available data in the literature [47], the LOD for the (9,4) chirality of DAN1‐SWCNT is very similar, with the literature value being 11 nM and ours 13 nM. The reported K value was 433 nM, whereas ours was 842 nM. This difference may arise from batch‐to‐batch variation, as K depends on the number of binding sites on the SWCNT, which is determined during the functionalization process.

2.2. Spatiotemporal Fluorescence Imaging

To capture spatiotemporal changes in SWCNT fluorescence in response to analytes, fluorescence imaging was conducted with immobilized SWCNTs within PLL‐treated microfluidic channels (Scheme 1A). The immobilized DNA‐SWCNTs were exposed to the respective analyte, followed by a wash, in a controlled, cyclic manner using two automated and synchronized syringe pumps to alternate analyte and PBS flows through the channel (Scheme 1B), with four cycles in total. Each cycle started with an 8 min PBS wash at a flow rate of 900 µL·min−1 either to equilibrate the channel in the first cycle or to remove residual analyte in subsequent cycles (Scheme 1C). The analyte concentrations were selected based on the dynamic response ranges previously determined from bulk calibration, ensuring that the tested concentrations fell within the responsive regime of each DNA‐SWCNT sample and that the lowest concentration remained at or above the bulk LOD. As the microfluidic setup was assumed to maintain laminar flow in the channel, analyte dispersion perpendicularly to the flow direction relied solely on diffusion. Accordingly, for DNA1‐SWCNT and DNA2‐SWCNT, we introduced the DA and TCh analytes, respectively, for 3 min at the same rate to reach the syringe bulk concentration throughout the channel. Then, the pumps were paused for 3 min to verify that no additional fluorescence changes occurred due to further diffusion, ascertaining complete equilibration. For DNA3‐SWCNTs, which displayed distinct kinetics as described below, we extended the 5‐HT analyte‐flow and no‐flow segments to 5 and 10 min, respectively. Movies of the entire process were taken for each DNA‐SWCNT and analyte concentration (Movies S1–S15).

SCHEME 1.

SCHEME 1

Experimental setup. (A) Functionalized SWCNTs immobilized in microfluidic channels. (B) The immobilized SWCNTs were exposed to the analyte and washed in a cyclical manner using two synchronized and automated syringe pumps with alternating flow, and their NIR fluorescence was recorded using a fluorescence microscope coupled to a NIR camera. (C) During analyte flow, the analyte was uniformly distributed within the channel, interacting with the immobilized SWCNTs and modulating their fluorescence. During the wash step, the analyte molecules were removed from the channel to recover the original SWCNT fluorescence.

Figure 1 presents representative fields of view (FOVs) of NIR fluorescence images before and after analyte addition for each DNA‐SWCNT across the four cycles, and the corresponding measured mean FOV fluorescence intensity time traces. Figure S5 overlays the mean measured FOV fluorescence time traces of the four cycles in the flow experiment for each analyte concentration. The three DNA‐functionalized SWCNTs exhibited different behaviors across cycles, with the effects most pronounced at higher analyte concentrations. DNA1‐SWCNT and DNA2‐SWCNT both exhibited an immediate increase in fluorescence upon analyte introduction into the channel, followed by a gradual decrease during PBS wash as the analyte was cleared from the channel (Figure 1A–D). Baseline intensities prior to analyte addition, I 0, were largely stable across cycles, with an upward drift at higher analyte concentrations (≥20 µm DA and ≥100 µm TCh) (Figure S5A,B and Table S2), consistent with incomplete washout and residual analyte on the SWCNTs. The post‐analyte fluorescence, I, declined in later cycles at higher analyte concentrations for both sensors, but the underlying causes differed. For DNA1‐SWCNT, at ≥20 µm DA, the post‐analyte intensity decreased both across cycles and, within a given cycle, even while DA continued to flow and during the subsequent no‐flow period. This behavior implicates time‐ and concentration‐dependent DA polymerization [47, 84]. In contrast, DNA2‐SWCNTs maintained stable post‐analyte fluorescence within cycles, and a reduction between cycles at ≥10 µm TCh, which can likely be explained by diminished sensitivity after repeated exposures, since TCh shows negligible degradation over hours in neutral buffer [85].

FIGURE 1.

FIGURE 1

(A) NIR Fluorescence images of the FOV of DNA1‐SWCNTs before (top row) and after (bottom row) the addition of 100 µM DA during flow experiments for the four cycles. Scale bar = 10 µm. (B) Mean fluorescence value of the FOV throughout flow experiments of DNA1‐SWCNT with DA as an analyte. (C) NIR Fluorescence images of the FOV of DNA2‐SWCNTs before (top row) and after (bottom row) the addition of 10 nM TCh during flow experiments for the four cycles. Scale bar = 10 µm. (D) Mean fluorescence value of the FOV throughout flow experiments of DNA2‐SWCNT with TCh as an analyte. (E) NIR Fluorescence images of the FOV of DNA3‐SWCNTs before (top row) and after (bottom row) the addition of 50 µM 5‐HT during flow experiments for the four cycles. Scale bar = 10 µm. (F) Mean fluorescence value of the FOV throughout flow experiments of DNA3‐SWCNT with 5‐HT as an analyte. White background represents PBS flow, dark grey represents analyte flow, and light grey represents the stop of the pump's flow for panels B, D, and E.

DNA3‐SWCNT exhibited a distinct kinetic profile in response to ≥ 1 µm 5‐HT, compared to the two other DNA‐SWCNTs. In the first cycle, fluorescence increased upon analyte introduction, then declined within the same cycle before the analyte flow was stopped. To rule out diffusion‐limited equilibration as the cause of the fluorescence drop, we extended the analyte‐flow period to 5 min. Moreover, to visualize the effect of the subsequent PBS wash under steady‐state conditions, we extended the stop‐flow interval to 10 min so the FOV stabilized before the next wash, ensuring any additional decrease would be attributed to washing alone (Figure 1F; Figure S5C). While 5‐HT can undergo polymerization similarly to DA, its polymerization process is significantly slower, spanning days [86, 87], and therefore unlikely to cause the diminished fluorescence. To corroborate that the transient decay is intrinsic to the DNA3‐SWCNT–5‐HT interaction, we performed continuous NIR spectroscopy assays of DNA3‐SWCNTs in solution phase with the addition of either 50 µm of 5‐HT or PBS as a control (Figure S6). Both traces showed a brief spike at the moment of addition, an expected artifact from pipette insertion, after which the PBS control remained stable at baseline. In contrast, the 5‐HT sample displayed short‐lived fluctuations attributable to diffusion and mixing within the well, followed by an increase and subsequent decrease in fluorescence in the absence of any flow. This rise‐then‐fall profile mirrors the behavior observed for the immobilized DNA3‐SWCNTs (Figure 1F), confirming that the post‐analyte decay originates from specific SWCNT‐analyte interaction rather than from the microfluidic experimental protocol. We note that the magnitude of attenuation observed in the bulk solution assay (Figure S6) is smaller than that measured in the imaging experiments (Figure 1F). This difference likely stems from the fact that the bulk spectroscopy response is calculated for the (9,4) chirality peak, whereas the imaging measurements quantify the mean fluorescence intensity across the FOV and therefore represent an average over a mixed chirality population of SWCNTs. Compared with subsequent cycles, DNA3‐SWCNTs show a modest decrease in the pre‐analyte baseline, I 0, and a pronounced reduction in post‐analyte fluorescence, I, after the first cycle (Figures 1E,F and 5C, Table S2).

FIGURE 5.

FIGURE 5

Reversibility Score of normalized fluorescence response, (I − I 0)/I 0, of the DNA‐SWCNTs to varying analyte concentrations across exposure cycles, using cycle‐specific baseline I 0. From left to right: DNA1‐SWCNTs with DA as an analyte, DNA2‐SWCNT with TCh as an analyte, DNA3‐SWCNT with 5‐HT as an analyte.

The normalized SWCNT fluorescence response of the entire FOV was calculated using two normalization schemes based on (I − I 0)/I 0. In both, I was the mean fluorescence intensity over 1 min after the response to the analyte. For the baseline, we either used (i) a cycle‐specific baseline I 0, defined as the mean fluorescence over the last 1 min of PBS wash immediately preceding that cycle's analyte exposure, or (ii) a fixed baseline I0(1), which is the corresponding PBS wash fluorescence intensity value from the first cycle, applied to all cycles. The cycle‐specific I 0 approach treats each cycle as an independent experiment and facilitates comparison of behavior across cycles when baselines drift. The fixed I0(1) assesses reversibility of I relative to the original pre‐analyte state, mimicking practical imaging in biological samples, where the true baseline after subsequent exposures may be ambiguous.

Due to the transient behavior of DNA3‐SWCNT in response to the analyte, we performed an analysis on the response kinetics of the DNA‐SWCNTs in order to determine the optimal time to measure I. First cycle responses normalized by I 0 were fitted to a difference of exponentials, analogous to multi‐exponential models commonly used to describe transient responses with multiple kinetic components [88], to describe both the rise in fluorescence prevalent in all DNA‐SWCNTs, and the decrease exhibited by DNA3‐SWCNT:

Ft=A·e−kdt−e−krt (2)

where A is a proportionality factor, and kr and kd are the rate constants of the increase and decrease in fluorescence, respectively.

The normalized first cycles and their fits are presented in Figure S7, and the fit parameters are summarized in Table S3. For DNA1‐SWCNT, the fitted kd value is zero for all DA concentrations, indicating that the response consists solely of a monotonic fluorescence increase without a decay component. Consequently, I could be measured at any chosen point during the response, preferably after 1/kr , without being affected by transient dynamics. DNA2‐SWCNT's response to TCh has a non‐zero kd value for all TCh concentrations except for 103 µM. For 102 and 104 µM TCh, the kd translates to a time constant (1/kr ) of 47 min and 3 h respectively, meaning any effect of the transient component would be negligible over the duration of 1 cycle. For 10 µM TCh, the kd translates to a time constant of 8.66 min, which could affect the signal within the 6 min of analyte exposure in a cycle. The response to 0.1 µM TCh exhibits kd and kr values of the same order of magnitude. In this case, I should be measured as early as possible to avoid interference from the transient component. DNA3‐SWCNT's responses to ≥ 5 µM 5‐HT show kd values that translate to time constants shorter than 8.1 min, meaning the transient decay component can affect the response within the 15 min of analyte exposure per cycle, and I should be measured sufficiently early. For concentrations 0.5 and 1 µM TCh, the kd values translate to time constants of 31 min and 2 h, respectively, so the transient decay component has a negligible effect on the response.

Since both DNA2‐SWCNT and DNA3‐SWCNT showed a transient component in their response to the analyte at some analyte concentrations, we decided to measure I as early as possible to avoid interference from the decay component with the measured normalized response. Since all responses are characterized by an initial sharp increase in fluorescence, measuring I before the fluorescence stabilizes would bias the response and lead to a large standard deviation. To determine the optimal measurement time, we calculated the coefficient of variation (CV), defined as the standard deviation divided by the mean of the fluorescence value I. The CV was computed over 1 min intervals starting at different times after the onset of the response (Figure S8). For all DNA‐SWCNT and analyte concentrations, the CV decreases initially and stabilizes shortly after the time constant of fluorescence increase, calculated as 1/kr , with the exception of DNA1‐SWCNT with 1 µM DA, where the CV stabilizes substantially prior to the time constant, due to the relatively small kr value (Table S3). To avoid interference of the transient component of the fluorescence responses, and to minimize the variation caused by the initial increase in fluorescence, the fluorescence I in each cycle was averaged over 1 min, starting at the time constant corresponding to the fluorescence increase (1/kr ) calculated for the first cycle of each DNA‐SWCNT and analyte concentration.

To evaluate how immobilized SWCNTs perform under repeated challenges, we quantified the normalized FOV response across cycles and concentrations using the two baselines, namely, the cycle‐specific I 0 (Figure 2A–C) and fixed first cycle I0(1) (Figure S9A–C). For DNA1‐SWCNTs and DA with the cycle‐specific baseline I 0, responses are relatively stable for <20 µm DA but decline for 20–100 µm in later cycles (Figure 2A). Using the fixed baseline I0(1) changes this trend, where for lower DA concentrations, the responses appear less consistent across cycles, whereas the responses at higher concentrations change less (Figure S9A). Taken together, these results indicate that near and beyond saturation, I is comparatively stable (except for a drop in the last cycle with 100 µm DA, attributed to DA polymerization) while I 0 drifts upward with cycles, consistent with residual DA. At low DA concentrations, on the other hand, the dominant effect is variations in I, which are less likely to occur when the binding sites on SWCNT are saturated with analyte.

FIGURE 2.

FIGURE 2

Normalized response of DNA‐SWCNT FOV for the different analyte concentrations and cycles, where the normalized response was calculated with both I  and I 0 values from the current cycle. (A) DNA1‐SWCNT with DA as an analyte. (B) DNA2‐SWCNT with TCh as an analyte. (C) DNA3‐SWCNT with 5‐HT as an analyte. (D) Normalized response of DNA‐SWCNT FOV from the first cycle compared to the (9,4) chirality calibration curve from Figure S4 for DNA1‐SWCNT with DA as an analyte. (E) DNA2‐SWCNT with TCh as an analyte. (F) DNA3‐SWCNT with 5‐HT as an analyte.

The responses of DNA2‐SWCNTs to TCh showed similar trends to those of DNA1‐SWCNT using the two methods of response calculation, where higher analyte concentrations show better consistency when using a fixed baseline. I0(1), (Figure 2B; Figure S9B). For the I0(1) analysis at ≥100 µM, the response in the second cycle is consistent with the first but decreases in the later cycles (Figure S9B), supporting a progressive loss of sensor sensitivity after repeated exposures rather than baseline drift or analyte degradation, as TCh is stable within the experimental timeframe. For lower TCh concentrations, cycle‐specific I 0 results in a more consistent response for all cycles, as with DNA1‐SWCNT, suggesting a more substantial change in I values for lower analyte concentrations.

For DNA3‐SWCNTs and 5‐HT, the responses using the same cycle I 0 show a significant loss of response after the first exposure for all 5‐HT concentrations (Figure 2C), consistent with the intrinsic rise‐then‐fall kinetics of this sensor‐analyte pair at the first cycle. Holding the baseline fixed using I0(1) yields a similar trend with an even more pronounced reduction in fluorescence response for all concentrations (Figure S9C), indicating that the dominant effect is a decrease in I after the first cycle, not baseline drift.

To benchmark immobilized sensors against ensemble behavior in the solution phase, we compared the first‐cycle imaging response at increasing analyte concentrations with bulk calibration obtained from fluorescence spectroscopy of the dominant (9,4) chirality (Figure 2D,E). Across all three DNA‐SWCNT—analyte pairs, the concentration‐response curves from imaging closely follow the bulk trends, indicating that immobilization and microfluidic handling preserve the fundamental sensing dynamics on initial exposure. The absolute amplitudes of response, however, differ by a scale factor. In bulk, the response is extracted from a specific chirality peak (9,4), whereas imaging integrates emission over the entire field of view from a heterogeneous mixture of chiralities and uses different collection optics and detectors. These methodological differences shift the response scale without altering its shape. Notably, the agreement in concentration dependence trends demonstrates that DNA‐SWCNTs retain their functionality after immobilization, validating first‐cycle imaging as a faithful proxy for bulk measurements.

2.3. Individual Regions of Interest (ROIs)

Monitoring immobilized SWCNTs enables the detection of localized biochemical events with high spatiotemporal resolution, which is a central motivation for single‐sensor imaging in tissues, cell cultures, and in vivo applications. Our platform is designed to rigorously characterize single‐sensor behavior, including response magnitude, recovery, and stability, thereby laying the groundwork for extracting quantitative information from spatiotemporal imaging. To identify individual SWCNTs, we utilized the iterative thresholding plugin in Fiji, which scans multiple thresholds above a user‐defined minimum and assigns each object the threshold at which its segmented area is most stable. Using this approach, SWCNTs‐containing regions of interest (ROIs) were detected for each flow experiment (Figure 3A). For the DNA1‐SWCNT, DNA2‐SWCNT, and DNA3‐SWCNT, between 423–623, 279–563, and 140–366 ROIs, representing 4.23%–7%, 2.37‐5.5%, and 1.22%–5% of the entire FOV were detected, respectively. After segmentation, we extracted the mean fluorescence intensity for every ROI over the entire time trace (Figure 3Ai,ii,iii). ROIs whose intensity at any time fell below three times the pre‐analyte FOV standard deviation (noise floor) were classified as washed away and excluded from further analysis. This workflow provides a robust, standardized basis for comparing single‐sensor responses across analytes, concentrations, and cycles, ultimately aiming to improve quantitative interpretation in high‐resolution imaging studies.

FIGURE 3.

FIGURE 3

(A) Segmented ROIs of individual SWCNTs in flow experiments of (GT)15‐SWCNT with 100 µm DA (Scale bar = 10 µm), with (i, ii, iii) three individual ROIs (scale bar = 500 nm) and their mean fluorescence intensity over time. (B) Mean fluorescence intensity traces of individual ROIs across all cycles for all analyte concentrations for DNA1‐SWCNTs and DA as an analyte, (C) DNA2‐SWCNTs and TCh as an analyte, and (D) DNA3‐SWCNTs and 5‐HT as an analyte.

Examination of individual ROIs highlights the intrinsic heterogeneity of the SWCNT population (Figure 3A). Nanotube ROIs can vary in length, size, and morphology, where additional diversity arises from mixed chiralities that are indistinguishable in the NIR images, and even within a single chirality, differences in the adsorbed corona conformation further contribute to this diversity [89]. Inspecting the mean fluorescence traces of representative ROIs across cycles (Figure 3Ai‐iii) reveals distinct behaviors. Some ROIs exhibit a consistent post‐analyte fluorescence, I, throughout cycles (Figure 3Ai), while others show a substantial increase in pre‐analyte fluorescence baseline, I 0, after the first cycle (Figure 3Aii), indicative of incomplete analyte washout. Additionally, some ROIs exhibited a decrease in I values after the first cycle exposure (Figure 3Aiii), which could be attributed to reduced sensitivity to the analyte upon repeated challenges. These observations reveal the variability in both the magnitude and reversibility of the fluorescence response across individual ROIs, which we further explore in subsequent sections.

Despite the variability in ROI fluorescence, when observing the fluorescence time trace of individual ROIs (Figure 3B–D), the fluorescence profile of the ROI populations closely tracks the FOV fluorescence behavior. All ROIs show an increase in intensity upon analyte introduction and a decrease during the PBS wash. Even in cases with minimal ensemble response, e.g., DNA2‐SWCNT at 0.1 µm TCh, the ROI population still shows a discernible rise upon TCh addition, especially in the first cycle (Figure 3C). These observations confirm that iterative segmentation indeed identifies SWCNTs, as evidenced by their stimulus responsiveness, and that the ROI ensemble is sufficiently large to capture the overall behavior observed at the FOV level.

With a representative population of SWCNT ROIs in hand, we next quantified single‐ROI fluorescence responses to each analyte. For every ROI, we computed the normalized response using both a cycle‐specific baseline, I 0 (Figure 4), and a fixed first‐cycle baseline I0(1) (Figure S10), as defined for the FOV analysis. Across all DNA‐SWCNTs, analyte concentrations, and cycles, the ROI responses span a wide range, with wider distributions at higher analyte concentrations.

FIGURE 4.

FIGURE 4

Distribution of the normalized fluorescence response ( I − I 0)/ I 0 to the corresponding analyte across cycles in the segmented ROI population for each DNA‐SWCNT and analyte concentration, where I and I 0 values both taken from the same cycle. (A) DNA‐SWCNT with DA as an analyte. (B) DNA2‐SWCNT with TCh as an analyte. (C) DNA3‐SWCNT with 5‐HT as an analyte. Statistical significance was analyzed using one‐way ANOVA tests, n.s.p>0.05, * p < 0.05, ** p < 0.01, *** p < 0.001.

Notably, the imaging or fluorescence characteristics of the ROIs alone cannot account for this variability. Visualization of the spatial distribution and normalized responses of the segmented ROIs for the first cycle of the flow experiments (Figure S11) reveals no clear dependence of the response on ROI position or size. To further examine potential relationships, we calculated Pearson correlations between normalized ROI responses and several ROI characteristics: area (Figure S12), baseline fluorescence, I 0 (Figure S13), and the standard deviation of baseline fluorescence, σ(I 0), representing variation in emitted fluorescence of the ROI (Figure S14). In all cases, only weak correlations were observed. Across conditions, correlations between first‐cycle response and ROI area, baseline fluorescence, and baseline fluorescence standard deviation ranged from −0.096 to 0.341 (Figure S12), −0.292 to 0.175 (Figure S13), and −0.512 to 0.117 (Figure S14), respectively. Instead, intrinsic heterogeneity is the more plausible driver, specifically, differences in SWCNT chirality, which were also manifested in the chirality‐dependent response amplitudes in bulk calibrations, with increasing variability for higher analyte concentrations (Figure S4), and in corona conformations that can vary even among nanotubes of the same chirality. The consequence of this heterogeneity is substantial overlap between the response distributions for neighboring concentrations, which limits quantitative inference at true single‐sensor resolution. To disentangle the respective contributions of chirality and corona structure, and to possibly tighten the response distributions, studies may employ single‐chirality SWCNT samples and more controlled corona architectures.

The ROI‐level response distributions computed with both baselines, cycle‐specific I 0 (Figure 4) and fixed I0(1) (Figure S10), track the same trends observed at the FOV level (Figure 2, Figure S9), further confirming that the segmented ROIs constitute a representative SWCNT population of the entire FOV. We then used one‐way ANOVA to assess reversibility by testing for statistically significant differences in ROI responses between the first cycle and later cycles.

DNA1‐SWCNTs showed a significant difference between first and later cycles for most of the conditions (Figure 4A; Figure S10A). For the responses calculated with I0(1), some of the distributions had a lower significance level, or none, compared to the I 0 case (the second and third cycles of 20 µm, all cycles for 50 µm, and the second cycle for 100 µM), indicating that at high DA concentrations, ≥20 µm, I remains comparatively stable across cycles, and the apparent variability is dominated by baseline drift, as observed for the entire FOV, with DA polymerization affecting later cycles for ≥20 µm. At low DA levels of 0.1 µm, changes in response in the second cycle are more pronounced than calculated with I0(1), suggesting I value changes after analyte exposure, which is further explored in subsequent sections.

For I 0‐based responses of DNA2‐SWCNT, statistical differences were weaker at ≤10 µm TCh and stronger at ≥100 µm (Figure 4B). Using I0(1), increased significance at low TCh levels but somewhat decreased the significance for the high concentrations, primarily in the second cycle (Figure S10B). This suggests that higher TCh concentrations yield more consistent I across cycles, whereas lower concentrations show larger cycle‐to‐cycle changes in I.

In the case of DNA3–SWCNT with 5‐HT, responses were highly significant (p < 0.001) for all concentrations and cycles in both normalization schemes, except the second cycle at 1 µm when using I 0 (Figure 4C; Figure S10C). This pervasive significance indicates poor recovery of both I and I 0 after the first 5‐HT exposure, consistent with the intrinsic rise‐then‐fall kinetics and subsequent loss of responsiveness described earlier.

Surface immobilization introduces three key considerations for comparing imaging to bulk measurements. First, PLL‐mediated electrostatic adsorption may preferentially immobilize SWCNTs with higher charge density, longer length, or chirality‐dependent properties. However, single‐ROI response distributions span the full range expected from mixed chiralities (Figure 4), rather than clustering around a narrow subset, and no correlation exists between ROI physical characteristics (area, position, baseline intensity) and normalized response (Figures S11–S14). Second, surface adsorption fixes the DNA‐SWCNT complex in a specific geometry that may differ from the equilibrium corona conformation in free solution, potentially altering analyte binding affinity or selectivity. Core recognition function is nevertheless preserved, as first‐cycle imaging recapitulates bulk calibration curves (Figure 2D–F). Third, SWCNTs adsorbed flat on PLL‐coated glass have some binding sites occluded from analyte access. Despite this geometric constraint, sensing responses remain robust relative to bulk (Figure 2D–F), as analyte binding to the exposed SWCNT surface produces measurable intensity changes.

2.4. SWCNT Reversibility

When using immobilized SWCNTs to monitor analyte presence with high spatial resolution, the same SWCNT can be used repeatedly, undergoing multiple exposures to the analyte. The reversibility of SWCNT is therefore fundamental for reliable long‐term sensing. To further investigate the reversibility of individual SWCNT and SWCNT populations, we compared I 0 values of individual ROIs in later cycles and their first‐cycle baseline I0(1) (Figures S15–S17). For each ROI, we also estimated the baseline noise as the standard deviation of the pre‐analyte trace, and points whose. I 0 shifts exceeded this noise were flagged in red, indicating changes not attributable to system fluctuations. Data points that fell within this noise level were plotted in green.

For DNA1‐SWCNTs and DNA2‐SWCNTs, at lower analyte concentrations (≤1 µm DA or ≤1000 µm TCh, respectively), ROIs showed both increases and decreases in I 0 relative to I0(1) (Figures S15–S16). At higher concentrations, the I 0 values overwhelmingly increase from the original I0(1) across the ROI populations. Prior work shows that ssDNA coronas (including (GT)15) can reconfigure upon analyte interaction, and SWCNT chirality also influences ssDNA conformation, which can alter the local dielectric environment and charge transfer near the SWCNT, thereby affecting the SWCNT fluorescence [47, 89, 90, 91, 92, 93] I 0 shifts at low concentrations could stem from corona remodeling with analyte exposure, as the original corona conformation may not be fully restored following analyte removal. ROI‐specific upward or downward I 0 shifts support this assumption, as the different corona configurations of SWCNT chiralities could result in different remodeling of the corona after analyte wash, causing differing effects on SWCNT fluorescence. At higher concentrations, however, the near‐universal increase in I 0 suggests a uniform effect on SWCNT corona after analyte wash, which is consistent with incomplete analyte removal (residual DA or TCh).

DNA3‐SWCNT ROIs, in contrast, exhibit a consistent decrease in I 0 values after the first cycle of 5‐HT exposure, for all concentrations and subsequent cycles (Figure S17). Together with the unique rise‐and‐fall behavior of DNA3‐SWCNT during the first analyte exposure (Figure S5C), this suggests that the first analyte challenge induces a substantial change in SWCNT functionalization and corona, which in turn decreases the SWCNT fluorescence during the first cycle and limits subsequent recovery afterward.

We next compared changes in post‐analyte intensity I to changes in baseline I 0 values for individual ROIs between the later and first cycles. To better understand the relationship between the changes in fluorescence values across cycles, a linear regression was performed, and the R2 value and the slope of the regression were calculated (Figures S18–S20). For DNA1‐SWCNT and DNA2‐SWCNT, the R2 and slope values present an overall decreasing trend with increasing analyte concentrations. This suggests that at lower analyte concentrations, the changes in fluorescence values between cycles better adhere to a linear relationship (Figures S18–S19). This behavior, together with the observations of the changes in I 0 values (Figures S15–S16), suggests that for lower analyte concentrations, the changes in I values between cycles are linearly dependent on I 0 changes. If baseline shifts arise from analyte‐induced corona reconfiguration, this linearity suggests that changes in I values might also be caused by changes in the corona, implying the response mechanism of the SWCNTs remains intact while the system “resets” to a new baseline. This explains the better apparent reversibility when responses are normalized to the cycle‐specific I 0 rather than the fixed I0(1) at low concentrations (Figure 4A,B; Figure S10A, B), and it implies that reliable quantification under repeated low‐dose exposures benefits from updating I 0 after each challenge. For higher analyte concentrations, the linear relationship between I and I 0 changes is less pronounced, with smaller R 2 and slope values, as I is relatively consistent while I 0 increases. As previously discussed, the increase in I 0 values is likely due to incomplete washing of analyte molecules from the SWCNTs. The relatively consistent I values may reflect the lack of “reset” of baseline corona conformation when the analyte remains bound, or saturation of binding sites at high analyte concentrations, which reduces variability in I values. For both DNA1‐SWCNT and DNA2‐SWCNT, there is a uniform decrease in I values of the ROIs across cycles for higher analyte concentrations (≥20 µm DA, ≥10 µm TCh). While the effect in DNA1‐SWCNT is likely due to DA polymerization, as discussed previously, for DNA2‐SWCNT, the effect is not attributable to analyte degradation, thus could be explained by a decreased sensitivity after multiple challenges.

For DNA3‐SWCNT, the R 2 and slope values of the linear regression also exhibit a decreasing trend with increasing 5‐HT concentrations (Figure S20). However, as described before, the majority of ROIs show a substantial decrease in both I and I 0 values, especially in higher 5‐HT concentrations. This pattern indicates that analyte‐induced corona changes are sufficiently strong to irreversibly decrease baseline fluorescence and reduce the sensitivity of SWCNTs, compromising reversibility in subsequent exposures.

2.5. Population Reversibility Score

To summarize recovery behavior in a single, comparable metric, we defined a Population Reversibility Score (PRS) applicable to any model of sensor‐analyte pair. The immobilized sensor population in our imaging experiments is heterogeneous, comprising mixtures of chiralities and variations in corona conformation (even within a given chirality), length, and surface‐adsorption morphology. The PRS therefore quantifies reversibility at the population level, ensuring that the assessment reflects the collective DNA‐SWCNT behavior. Importantly, the framework itself is general and can also be applied to single‐chirality samples, where it would quantify reversibility for that specific sensor population.

We quantify reversibility directly from the distribution of ROI responses in each experiment. For every cycle and concentration, the ROI responses are converted into a probability density using kernel density estimation (KDE), a non‐parametric method that estimates the probability density function of a random variable based on a finite set of data samples [94]. We then measure the statistical distance to a reference distribution, namely, the first‐cycle distribution at the same concentration, using the Kullback‐Leibler (KL) Divergence (relative entropy) [95]:

DKLP||Q=∫PxlogPxQxdx (3)

where P and Q denote the cycle‐specific and reference response distributions, respectively. The relative entropy is a non‐negative measure that quantifies how one probability distribution diverges from another, and it equals zero only when the two distributions are identical. Thus, it increases as the cycle's distribution departs from its first‐cycle counterpart, capturing changes arising from any source of variability within the heterogeneous population. To map this unbounded distance to an intuitive, unitless score in the range of [0, 1], we define the PRS to be:

PRS=e−DKL (4)

By construction, PRS  =  1 indicates perfect recovery (the cycle's distribution matches the first cycle), whereas PRS values approaching 0 indicate poor reversibility. For each cycle, the PRS and its standard deviation were calculated using a bootstrapping resampling method (N = 100 iterations). This cycle‐ and concentration‐dependent PRS compresses the full population statistics into a single number, enabling standardized comparisons across constructs, doses, and experimental conditions.

We computed the PRS using both normalization schemes, cycle‐specific I 0 (Figure 5) and fixed I0(1)(Figure S21), to assess how reversibility depends on analyte concentration, number of exposures, and baseline choice. These results align with previous observations, in which both analyte type and concentration affect the attenuation of the fluorescence response and, thus, the reversibility. At lower analyte concentrations, all three DNA‐SWCNTs achieve higher PRS when responses are normalized to the cycle‐specific baseline I 0, consistent with previous observations of the stronger linearity in the change of I 0 and I values between cycles for lower analyte concentrations, suggesting corona conformation change due to SWCNT‐analyte interaction can cause a permanent change in the surface conformation even after analyte wash, causing a change in future responses. At higher concentrations, the trend flips for DNA1‐SWCNTs (DA) and DNA2‐SWCNTs (TCh), where PRS is higher with the fixed baseline I0(1), indicating that the post‐analyte intensity I remains comparatively stable while I 0 drifts (e.g., due to residual analyte). This, again, aligns with previous observations, suggesting high analyte concentration prevents change in baseline surface conformation due to insufficient wash, or that the saturation of binding sites reduces possible variation of the fluorescence response. DNA3‐SWCNT (5‐HT) exhibits lower PRS scores for fixed baseline response, likely due to its unique rise and fall response dynamics, which caused a reduced baseline and sensitivity of the SWCNTs after the first 5‐HT exposure. This suggests that for some SWCNT‐analyte pairs, changes in surface conformation following analyte exposure may reduce sensitivity in subsequent exposures. Beyond baseline choice, the PRS captures the cumulative impact of repeated challenges. For most concentrations and SWCNT constructs, PRS decreases with cycle number, revealing a practical limit to the number of exposure‐wash cycles the DNA‐SWCNT can undergo before reversibility degrades.

The PRS highlights functionalization‐dependent differences in SWCNT reversibility and, therefore, should be assessed for any sensor intended for long‐term imaging to judge whether consecutive measurements are valid and comparable. For sensors with high PRS across multiple exposures, sequential readouts from long‐term imaging could be considered reliable for comparisons and concentration estimates. However, when PRS is low or declines with cycling, quantitative use requires prior multi‐cycle calibration (or limiting the number of exposures), as the response cannot be assumed to be reversible. Beyond flagging stability, PRS also indicates the preferred normalization strategy (e.g., cycle‐specific I 0 vs. fixed I0(1)) and guides experimental choices on whether to re‐baseline between cycles, limit analyte concentration ranges, strengthen wash protocols, or cap the number of exposure‐wash rounds.

3. Conclusion

In this work, we established a controlled microfluidics imaging‐based platform to quantify how optical nanosensors respond and recover under repeated analyte challenges. The reversibility of the SWCNTs is a critical parameter for their reliable long‐term use as fluorescence‐based analyte sensors. Notably, first‐cycle responses of immobilized sensors tracked ensemble (bulk) calibration, confirming that the core concentration‐dependent response dynamics are preserved upon immobilization. Nevertheless, by resolving hundreds of individual sensor ROIs and analyzing pre‐analyte and post‐analyte fluorescence intensity modulations across multiple analyte exposure cycles, we revealed broad variability in response magnitude and signal recovery, and we linked multi‐cycle changes to analyte‐ and dose‐dependent mechanisms. For DNA1‐SWNCT and DNA2‐SWCNT, at lower analyte concentrations, individual ROIs generally retained their fluorescence response dynamics despite shifts in baseline fluorescence, suggesting that initial analyte exposure induced a change in corona conformation without permanently impairing sensing function. In contrast, higher analyte concentrations led to systematic increases in baseline fluorescence, likely due to incomplete analyte washout and residual adsorption on the sensor surface, thereby limiting sensor recovery. DNA3‐SWCNT exhibited a distinct rise‐then‐fall behavior with an irreversible decrease in fluorescence, indicating stronger or more disruptive analyte interactions with the corona layer of the SWCNTs. While the ROIs were identified using iterative thresholding in this work, recent studies have established an ML‐based approach for SWCNT ROI segmentation that can isolate analyte‐specific signals from subtle noise, improving measured sensor sensitivity and LOD [96]. Future implementations could leverage this technique for high‐precision mapping and potentially further refine the population reversibility metrics described here.

A key design choice in this first demonstration was to work with mixed‐chirality samples, which posed a greater challenge for quantifying reversibility. The immobilized populations include multiple chiralities, in addition to heterogeneity in length, corona conformation, and surface‐adsorbed morphology, which can arise stochastically when casting onto substrates or immobilizing in hydrogels/tissues. This heterogeneity increases the distributional spread and concentration overlap at the single‐sensor level, thereby stress‐testing any metric that aims to summarize recovery. Although using single‐chirality materials can narrow variance, even such samples retain inherent heterogeneity in corona states, lengths, and adsorption geometries, and a population‐level measure of reversibility therefore remains necessary.

To standardize reporting across constructs, concentrations, and cycles, we introduced the Population Reversibility Score (PRS), derived from the KL divergence between cycle‐specific and first‐cycle response distributions. PRS maps distributional differences onto a unitless [0, 1] scale, with PRS = 1 representing perfect recovery, enabling robust and generalizable comparisons of long‐term operational stability. This score accurately summarizes the progressive loss of fluorescence response reversibility across repeated cycles, demonstrating its dependence on both analyte concentration and the number of exposures. Furthermore, the analysis highlighted that the choice of baseline calculation is crucial for maximizing apparent reversibility. As a general guideline, a cycle‐specific baseline should be employed for low analyte concentrations, reflecting a true “system reset”, while a fixed first‐cycle baseline is better suited for high‐concentration assays, as it is not skewed by the baseline drift prominent at higher analyte concentrations.

More broadly, our platform and the Population Reversibility Score are agnostic to the specific SWCNT‐analyte pairing and can be extended to other corona chemistries, target molecules, and chirality enrichment strategies. Beyond SWCNTs, the same workflow of microfluidic cycling, single‐sensor (or single‐ROI) distributional analysis, and KL‐based reversibility scoring applies to any sensing modality that relies on a transient signal to report analyte presence over time. As such, this framework offers a general path to standardize and compare long‐term recovery in systems designed for continuous, high‐resolution monitoring in complex environments.

4. Experimental Section

4.1. Materials

HipCO SWCNTs were purchased from NanoIintegris. Single‐stranded DNA sequences were purchased from Integrated DNA Technologies. Dopamine hydrochloride was purchased from Sigma‐Aldrich, Thiocholine Iodide from BOC Sciences, and Serotonin (hydrochloride) from Cayman Chemical.

4.2. SWCNT Suspension Preparation

HipCO SWCNTs were dispersed with three ssDNA sequences, (GT)15 (DNA1), T30 (DNA2), and CCC CCC AGC CCT TCA CCA CCA ACT CCC CCC (DNA3), in NaCl (0.1 m) using bath sonication (Elma P‐30H, 80 Hz) followed by tip sonication on ice (Qsonica Q125, 3 mm tip, 4 W). For DNA1 and DNA2, SWCNTs (1 mg) with ssDNA (2 mg) were bath‐sonicated for 10 min and tip‐sonicated twice for 20 min each, whereas for DNA3, SWCNTs (1 mg) with ssDNA (100 µm) were bath‐sonicated for 2 min and tip‐sonicated for 10 min, according to the protocol in Kelich et al. [48]. All suspensions were then centrifuged twice at 16,100 rcf (DNA1 and DNA2 for 90 min per spin, and DNA3 for 30 min per spin), each time collecting the top 80% of the supernatant.

4.3. Absorption Spectroscopy

The absorption of the suspensions was recorded between 200 and 1400 nm (1 nm step size) using a UV–vis–NIR spectrophotometer (Shimadzu UV‐3600 PLUS). The concentration of the suspension was calculated according to the absorption measured at 632 nm, using an extinction coefficient of ε632nm = 0.036 L·mg−1·cm−1 [47].

4.4. Excitation‐Emission Spectra

SWCNT solutions (0.5 mg·L−1) in PBS (pH 7.4) were illuminated using a supercontinuum white‐light laser (NKT‐photonics, Super‐K Extreme) with a bandwidth filter (NKT‐photonics, Varia, Δλ = 20 nm). They were scanned between 450 nm and 840 nm with a 2 nm wavelength step size, at an intensity of 20 mW (at 730 nm). Emission spectra were recorded by a NIR inverted fluorescence microscope (Olympus IX73), and spectrally resolved using a spectrograph (Spectra Pro HRS‐300, Princeton Instruments) with a slit‐width of 500 µm and a grating (150 g·mm−1). An InGaAs camera (PylonIR, Teledyne Princeton Instruments) was used to record the fluorescence intensity spectra.

4.5. NIR Fluorescence Spectroscopy

In a 96‐well plate, functionalized SWCNT solutions (0.5 mg·L−1) in PBS were added to each well, followed by the addition of analytes in different concentrations. The well plate was mounted on the stage of the inverted microscope (Olympus IX73) and illuminated by a supercontinuum white‐light laser, as described above, at an excitation wavelength of 730 nm with an intensity of 20 mW.

4.6. Continuous NIR Fluorescence Spectroscopy

A 96‐well plate, with 145 µm of DNA3‐SWCNT solution (0.5 mg·L−1) in PBS per well, was placed on a mounted stage of the inverted microscope (Olympus IX73), and illuminated by a 730 nm continuous‐wave laser (MDL‐MD‐730 1.5 W, Changchun New Industries) with an intensity of 100 mW. The fluorescence emission was recorded continuously with an exposure time of 2 s and spectrally resolved as described above. After a 1 min baseline, 5 µL of either PBS or serotonin (final concentration of 50 µM) was added.

4.7. SWCNTs Immobilization

For flow experiments, Ibidi µ‐slides VI 0.1 were used. The channels were incubated with PLL (Poly‐L‐Lysine) (5 µL, 0.01%) for 10 min, washed with ddH2O, and dried. Then, functionalized SWCNT solution (0.5 mg·L−1, 5 µL) in PBS was added to the channels for 10 min incubation, washed with PBS, and dried. All channels were filled with PBS (90 µL) to maintain SWCNT hydration until imaging.

4.8. Fluorescence Imaging

The prepared slide was placed on the stage of an inverted fluorescence microscope (Olympus IX83) equipped with a UPLFLN 100X objective lens, 1.3 NA. Two syringes, filled with medium (PBS) and analyte solution, were placed in automated syringe pumps (SyringeTwo, NewEra) and connected to the channel through a tubing system. The medium and analyte were flowed through the channel at a flow rate of 900 µL·min−1. During the flow experiment, the SWCNT fluorescence was excited by a 730 nm continuous‐wave laser (MDL‐MD‐730 1.5 W, Changchun New Industries) with an intensity of 500 mW. The laser excitation light was directed to the sample by a dichroic mirror (900 nm lp, chroma, T900lpxxrxt), and the NIR emission of the SWCNTs was detected after an additional 900 nm long‐pass emission filter (chroma, ET900lp) with an InGaAs camera (Raptor, Ninox 640 VIS‐SWIR).

4.9. Image Processing

All images were processed using Fiji (ImageJ) and MATLAB, as detailed below.

4.10. Field‐of‐View (FOV) Response Calculation

The mean fluorescence intensity of the entire FOV was calculated for each frame of the acquired image stack throughout the experiment. The normalized FOV response was defined as (I − I 0)/I 0, where I is the mean FOV fluorescence intensity averaged over a 1 min post‐analyte measurement window, and I 0 is the pre‐analyte baseline fluorescence. Two normalization schemes were applied in parallel: (i) a cycle‐specific baseline I 0, defined as the mean FOV fluorescence over the last minute of the buffer wash immediately preceding each cycle's analyte exposure; and (ii) a fixed first‐cycle baseline I0(1), defined as the I 0 value from the first cycle, applied uniformly to all subsequent cycles.

To determine the optimal timing of the I measurement window, first‐cycle FOV normalized responses were fitted to a difference‐of‐exponentials model Equation (2) using nonlinear least‐squares optimization in MATLAB. This model captures both monotonically increasing responses and transient fluorescence decay. To ensure that I was measured after sufficient fluorescence increase but prior to significant transient decay, I was defined as the mean FOV fluorescence averaged over a 1 min window beginning at t  =  1/kr after the start of analyte introduction, where kr is the rate constant corresponding to the increasing fluorescence response determined from the first‐cycle fit for each DNA‐SWCNT–analyte pair across the different analyte concentrations and applied consistently to all subsequent cycles.

4.11. ROI Segmentation

Individual SWCNT‐containing regions of interest (ROIs) were identified using the 3D Iterative Thresholding plugin in Fiji (ImageJ), applied to a reference image of the SWCNT fluorescence after analyte introduction in the first cycle. The plugin employs the MSER (Maximally Stable Extremal Regions) criterion, which scans a range of intensity thresholds above a user‐defined minimum and assigns each candidate object the threshold value at which its segmented area is most stable, i.e., changes the least between adjacent thresholds. This criterion was chosen as it is robust to local contrast variations inherent to sparsely distributed, diffraction‐limited SWCNT emitters. The only user‐defined parameter is the minimum threshold, which was set to the mean fluorescence intensity of the reference frame. All other segmentation parameters (threshold step size, stability tolerance, and minimum/maximum object area) were held constant across all experiments using default values. For the DNA1‐SWCNT, DNA2‐SWCNT, and DNA3‐SWCNT experiments, this procedure identified between 423–623, 279–563, and 140–366 ROIs, representing 4.23%–7%, 2.37%–5.5%, and 1.22%–5% of the total FOV area, respectively.

4.12. Per‐ROI Intensity Extraction

For each ROI and each frame, the mean fluorescence intensity within the ROI boundary was computed, yielding a per‐ROI intensity time trace spanning the complete duration of the experiment. ROIs whose mean intensity dropped below three times the standard deviation of the pre‐analyte FOV intensity (the noise floor) at any point during the experiment were classified as washed away or otherwise lost from the field of view and were excluded from all subsequent analyses. The fluorescence response of each ROI was calculated in the same way as detailed for the FOV response.

4.13. Population Reversibility Score

For each cycle and concentration, the distribution of per‐ROI normalized responses was modelled as a continuous probability density function using kernel density estimation (KDE). The KL divergence from the first‐cycle distribution to the current cycle's distribution was then computed as detailed in Equation (3), and the Population Reversibility Score (PRS) was defined as described in Equation (4), mapping the unbounded divergence to a unitless [0,1] scale. To estimate the uncertainty in the PRS, a bootstrapping procedure was applied, where N = 100 bootstrap resamples (with replacement) of the ROI population were generated, the PRS was computed for each resample, and the mean PRS score and its standard deviation were calculated across all samples.

Conflicts of Interest

The authors declare no conflicts of interest.

Supporting information

Supporting File 1: smll73339‐sup‐0001‐SuppMat.pdf.

Supporting File 2: smll73339‐sup‐0002‐MovieS1.mp4.

Download video file (2.3MB, mp4)

Supporting File 3: smll73339‐sup‐0003‐MovieS2.mp4.

Download video file (7.1MB, mp4)

Supporting File 4: smll73339‐sup‐0004‐MovieS3.mp4.

Download video file (1.4MB, mp4)

Supporting File 5: smll73339‐sup‐0005‐MovieS4.mp4.

Download video file (2.3MB, mp4)

Supporting File 6: smll73339‐sup‐0006‐MovieS5.mp4.

Download video file (1.8MB, mp4)

Supporting File 7: smll73339‐sup‐0007‐MovieS6.mp4.

Download video file (2.7MB, mp4)

Supporting File 8: smll73339‐sup‐0008‐MovieS7.mp4.

Download video file (1.4MB, mp4)

Supporting File 9: smll73339‐sup‐0009‐MovieS8.mp4.

Download video file (1.1MB, mp4)

Supporting File 10: smll73339‐sup‐0010‐MovieS9.mp4.

Download video file (1.2MB, mp4)

Supporting File 11: smll73339‐sup‐0011‐MovieS10.mp4.

Download video file (1.2MB, mp4)

Supporting File 12: smll73339‐sup‐0012‐MovieS11.mp4.

Download video file (3.2MB, mp4)

Supporting File 13: smll73339‐sup‐0013‐MovieS12.mp4.

Download video file (1MB, mp4)

Supporting File 14: smll73339‐sup‐0014‐MovieS13.mp4.

Download video file (1.2MB, mp4)

Supporting File 15: smll73339‐sup‐0015‐MovieS14.mp4.

Download video file (1.2MB, mp4)

Supporting File 16: smll73339‐sup‐0016‐MovieS15.mp4.

Download video file (706.4KB, mp4)

Acknowledgements

G.B. acknowledges the support of the Zuckerman STEM Leadership Program, the ERC NanoNonEq 101039127, the Israel Science Foundation (Grant No. 196/22), the Ministry of Science, Technology, and Space, Israel (Grant Nos. 1001818370 and 1001944224), the Marian Gertner Institute for Medical Nanosystems at Tel Aviv University, the Nicholas and Elizabeth Slezak Super Center for Cardiac Research and Biomedical Engineering at Tel Aviv University, the Tel Aviv University Center for AI and Data Science (TAD), the Zimin Institute for Engineering Solutions Advancing Better Lives, and the Naomi Prawer Kadar Foundation. G.R. acknowledges the support of the Council for Higher Education and the Excellence Fellowship from the Faculty of Engineering, Tel Aviv University.

Data Availability Statement

The data that support the findings of this study are available from the corresponding author upon reasonable request.

References

  • 1. Morales M. A. and Halpern J. M., “Guide to Selecting a Biorecognition Element for Biosensors,” Bioconjugate Chemistry 29, no. 10 (2018): 3231–3239, 10.1021/acs.bioconjchem.8b00592. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Flynn C. D., Chang D., Mahmud A., et al., “Biomolecular Sensors for Advanced Physiological Monitoring,” Nature Reviews Bioengineering 1, no. 8 (2023): 560–575, 10.1038/s44222-023-00067-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Koren S. A., Ahmed Selim N., De la Rosa L., et al., “All‐optical Spatiotemporal Mapping of ROS Dynamics across Mitochondrial Microdomains in Situ,” Nature Communications 14, no. 1 (2023): 6036, 10.1038/s41467-023-41682-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Wan J., Peng W., Li X., et al., “A Genetically Encoded Sensor for Measuring Serotonin Dynamics,” Nature Neuroscience 24, no. 5 (2021): 746–752, 10.1038/s41593-021-00823-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Patriarchi T., Cho J. R., Merten K., et al., “Ultrafast Neuronal Imaging of Dopamine Dynamics with Designed Genetically Encoded Sensors,” Science 360, no. 6396 (2018): aat4422, 10.1126/science.aat4422. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Gao F., Liu C., Zhang L., et al., “Wearable and Flexible Electrochemical Sensors for Sweat Analysis: a Review,” Microsystems & Nanoengineering 9, no. 1 (2023): 1, 10.1038/s41378-022-00443-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Goode J. A., Rushworth J. V. H., and Millner P. A., “Biosensor Regeneration: a Review of Common Techniques and Outcomes,” Langmuir 31, no. 23 (2015): 6267–6276, 10.1021/la503533g. [DOI] [PubMed] [Google Scholar]
  • 8. Bachilo S. M., Strano M. S., Kittrell C., Hauge R. H., and Smalley R. E., “Structure‐Assigned Optical Spectra of Single‐Walled Carbon Nanotubes,” Science 298, no. 5602 (2002): 2361–2366, 10.1126/science.1078727. [DOI] [PubMed] [Google Scholar]
  • 9. Li J. and Pandey G. P., “Advanced Physical Chemistry of Carbon Nanotubes,” Annual Review of Physical Chemistry 66 (2015): 331–356, 10.1146/annurev-physchem-040214-121535. [DOI] [PubMed] [Google Scholar]
  • 10. Yang F., Wang M., Zhang D., Yang J., Zheng M., and Li Y., “Chirality Pure Carbon Nanotubes: Growth, Sorting, and Characterization,” Chemical Reviews 120, no. 5 (2020): 2693–2758, 10.1021/acs.chemrev.9b00835. [DOI] [PubMed] [Google Scholar]
  • 11. Sims C. M., Zheng M., and Fagan J. A., “Single‐wall Carbon Nanotube Separations via Aqueous Two‐phase Extraction: New Prospects Enabled by High‐throughput Methods,” Chemical Communications 61, no. 10 (2025): 2026–2039, 10.1039/D4CC06096B. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. O'Connell M. J., Bachilo S. M., Huffman C. B., et al., “Band Gap Fluorescence from Individual Single‐Walled Carbon Nanotubes,” Science 297, no. 5581 (2002): 593–596, 10.1126/science.1072631. [DOI] [PubMed] [Google Scholar]
  • 13. Lin C. W. and In W. R. B., “In Vivo Detection of Single‐Walled Carbon Nanotubes: Progress and Challenges,” Nanomedicine 11, no. 22 (2016): 2885–2888, 10.2217/nnm-2016-0338. [DOI] [PubMed] [Google Scholar]
  • 14. Hang Y., Boryczka J., and Wu N., “Visible‐light and near‐infrared Fluorescence and Surface‐enhanced Raman Scattering Point‐of‐care Sensing and Bio‐imaging: a Review,” Chemical Society Reviews 51, no. 1 (2022): 329–375, 10.1039/c9cs00621d. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Hemmer E., Benayas A., Légaré F., and Vetrone F., “Exploiting the Biological Windows: Current Perspectives on Fluorescent Bioprobes Emitting above 1000 Nm,” Nanoscale Horizons 1, no. 3 (2016): 168–184, 10.1039/c5nh00073d. [DOI] [PubMed] [Google Scholar]
  • 16. Fan F., Zeng K., Zhu Y., et al., “Second Near‐Infrared Window Fluorescence Materials for in Vivo Dynamic Multiplexed Imaging,” Advanced Functional Materials 35, no. 31 (2025): 2422693, 10.1002/adfm.202422693. [DOI] [Google Scholar]
  • 17. Kruss S., Hilmer A. J., Zhang J., Reuel N. F., Mu B., and Strano M. S., “Carbon Nanotubes as Optical Biomedical Sensors,” Advanced Drug Delivery Reviews 65, no. 15 (2013): 1933–1950, 10.1016/j.addr.2013.07.015. [DOI] [PubMed] [Google Scholar]
  • 18. Jain A., Homayoun A., Bannister C. W., and Yum K., “Single‐Walled Carbon Nanotubes as near‐Infrared Optical Biosensors for Life Sciences and Biomedicine,” Biotechnology Journal 10, no. 3 (2015): 447–459, 10.1002/biot.201400168. [DOI] [PubMed] [Google Scholar]
  • 19. Iverson N. M., Barone P. W., Shandell M., et al., “In Vivo Biosensing via Tissue‐localizable near‐infrared‐fluorescent Single‐walled Carbon Nanotubes,” Nature Nanotechnology 8, no. 11 (2013): 873–880, 10.1038/nnano.2013.222. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Galassi T. V., Antman‐Passig M., Yaari Z., Jessurun J., Schwartz R. E., and Heller D. A., “Long‐term in Vivo Biocompatibility of Single‐walled Carbon Nanotubes,” PLoS ONE 15, no. 5 (2020): 0226791, 10.1371/journal.pone.0226791. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Gillen A. J. and Boghossian A. A., “Non‐covalent Methods of Engineering Optical Sensors Based on Single‐Walled Carbon Nanotubes,” Frontiers in Chemistry 7 (2019), 10.3389/fchem.2019.00612. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Farrera C., Torres Andón F., and Feliu N., “Carbon Nanotubes as Optical Sensors in Biomedicine,” ACS Nano 11, no. 11 (2017): 10637–10643, 10.1021/acsnano.7b06701. [DOI] [PubMed] [Google Scholar]
  • 23. Zhang Y., Guo J., Tang Z., et al., “Recent Developments and Trends of Biosensors Based on Carbon Nanotubes for Biomedical Diagnosis Applications: a Review,” Biosens Bioelectron X 17 (2024): 100424, 10.1016/j.biosx.2023.100424. [DOI] [Google Scholar]
  • 24. Levin N., Hendler‐Neumark A., Kamber D., and Bisker G., “Enhanced Cellular Internalization of near‐infrared Fluorescent Single‐walled Carbon Nanotubes Facilitated by a Transfection Reagent,” Journal of Colloid and Interface Science 664 (2024): 650–666, 10.1016/j.jcis.2024.03.039. [DOI] [PubMed] [Google Scholar]
  • 25. Ackermann J., Metternich J. T., Herbertz S., and Kruss S., “Biosensing with Fluorescent Carbon Nanotubes,” Angew Chem—Int Ed 61, no. 18 (2022): 202112372, 10.1002/anie.202112372. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Dewey H. M., Lamb A., and Budhathoki‐Uprety J., “Recent Advances on Applications of Single‐walled Carbon Nanotubes as Cutting‐edge Optical Nanosensors for Biosensing Technologies,” Nanoscale 16 (2024): 16344–16375, 10.1039/d4nr01892c. [DOI] [PubMed] [Google Scholar]
  • 27. Cohen Z. and Williams R. M., “Single‐Walled Carbon Nanotubes as Optical Transducers for Nanobiosensors in Vivo,” ACS Nano 18 (2024): 35164–35181, 10.1021/acsnano.4c13076. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Shabnum S. S., Siranjeevi R., Raj C. K., Nivetha P., and Benazir K., “A Comprehensive Review on Recent Progress in Carbon Nanotubes for Biomedical Application,” Environmental Quality Management 34, no. 3 (2025): 70040, 10.1002/tqem.70040. [DOI] [Google Scholar]
  • 29. Acharya R., Patil T. V., Dutta S. D., et al., “Single‐Walled Carbon Nanotube‐Based Optical Nano/Biosensors for Biomedical Applications: Role in Bioimaging, Disease Diagnosis, and Biomarkers Detection,” Advanced Materials Technologies 9, no. 20 (2024): 2400279, 10.1002/admt.202400279. [DOI] [Google Scholar]
  • 30. Zhang J., Landry M. P., Barone P. W., et al., “Molecular Recognition Using Corona Phase Complexes Made of Synthetic Polymers Adsorbed on Carbon Nanotubes,” Nature Nanotechnology 8, no. 12 (2013): 959–968, 10.1038/nnano.2013.236. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Basu S. and Bisker G., “Near‐Infrared Fluorescent Single‐Walled Carbon Nanotubes for Biosensing,” Small 21, no. 26 (2025): 2502542, 10.1002/smll.202502542. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Basu S., “The Importance of Defects in Controlling the Chemistry of Single‐Walled Carbon Nanotubes,” The Journal of Physical Chemistry Letters 16, no. 20 (2025): 5128–5139, 10.1021/acs.jpclett.5c00811. [DOI] [PubMed] [Google Scholar]
  • 33. Nandi S., Gresil Q., Lambert B. P., et al., “Ultrashort Carbon Nanotubes with Luminescent Color Centers Are Bright NIR‐II Nanoemitters,” ACS Nano 19, no. 21 (2025): 19818–19830, 10.1021/acsnano.5c02171. [DOI] [PubMed] [Google Scholar]
  • 34. Krasley A. T., Li E., Galeana J. M., Bulumulla C., Beyene A. G., and Demirer G. S., “Carbon Nanomaterial Fluorescent Probes and Their Biological Applications,” Chemical Reviews 124, no. 6 (2024): 3085–3185, 10.1021/acs.chemrev.3c00581. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Chen X., Wang D., Ding W., Zang H., and Li L., “Single‐walled Carbon Nanotubes Sensors: Preparation and Bio‐application Advances,” Pharmaceutical Science Advances 3 (2025): 100064, 10.1016/j.pscia.2025.100064. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Niidome Y., Wakabayashi R., Goto M., Fujigaya T., and Shiraki T., “Protein‐Structure‐Dependent Spectral Shifts of Near‐Infrared Photoluminescence from Locally Functionalized Single‐walled Carbon Nanotubes Based on Avidin–biotin Interactions,” Nanoscale 14, no. 36 (2022): 13090–13097, 10.1039/D2NR01440H. [DOI] [PubMed] [Google Scholar]
  • 37. Taborowska P., Dzienia A., and Janas D., “Unraveling Aryl Peroxide Chemistry to Enrich Optical Properties of Single‐walled Carbon Nanotubes,” Chemical Science 16, no. 3 (2025): 1374–1389, 10.1039/D4SC04785K. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38. Bisker G., Bakh N. A., Lee M. A., et al., “Insulin Detection Using a Corona Phase Molecular Recognition Site on Single‐Walled Carbon Nanotubes,” ACS Sensors 3, no. 2 (2018): 367–377, 10.1021/acssensors.7b00788. [DOI] [PubMed] [Google Scholar]
  • 39. Bisker G., Dong J., Park H. D., et al., “Protein‐targeted Corona Phase Molecular Recognition,” Nature Communications 7 (2016): 10241, 10.1038/ncomms10241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40. Lee M. A., Wang S., Jin X., et al., “Implantable Nanosensors for Human Steroid Hormone Sensing in Vivo Using a Self‐Templating Corona Phase Molecular Recognition,” Advanced Healthcare Materials 9, no. 21 (2020): 2000429, 10.1002/adhm.202000429. [DOI] [PubMed] [Google Scholar]
  • 41. Kuo M.‐T., Raffaelle J. F., Waller E. M., et al., “Screening Enzymatic Degradation of Polyester Polyurethane with Fluorescent Single‐walled Carbon Nanotube and Polymer Nanoparticle Conjugates,” ACS Nano 17, no. 17 (2023): 17021–17030, 10.1021/acsnano.3c04347. [DOI] [PubMed] [Google Scholar]
  • 42. Antonucci A., Kupis‐Rozmysłowicz J., and Boghossian A. A., “Noncovalent Protein and Peptide Functionalization of Single‐Walled Carbon Nanotubes for Biodelivery and Optical Sensing Applications,” ACS Applied Materials & Interfaces 9, no. 13 (2017): 11321–11331, 10.1021/acsami.7b00810. [DOI] [PubMed] [Google Scholar]
  • 43. Bakota E. L., Aulisa L., Tsyboulski D. A., Weisman R. B., and Hartgerink J. D., “Multidomain Peptides as Single‐Walled Carbon Nanotube Surfactants in Cell Culture,” Biomacromolecules 10, no. 8 (2009): 2201–2206, 10.1021/bm900382a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44. Petresky G., Faran M., Wulf V., and Bisker G., “Metal‐Ion Optical Fingerprinting Sensor Selection via an Analyte Classification and Feature Selection Algorithm,” Analytical Chemistry 97, no. 16 (2025): 8821–8832, 10.1021/acs.analchem.4c06762. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45. Wulf V. and Bisker G., “Single‐Walled Carbon Nanotubes as Fluorescent Probes for Monitoring the Self‐Assembly and Morphology of Peptide/Polymer Hybrid Hydrogels,” Nano Letters 22, no. 22 (2022): 9205–9214, 10.1021/acs.nanolett.2c01587. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46. Loewenthal D., Kamber D., and Bisker G., “Monitoring the Activity and Inhibition of Cholinesterase Enzymes Using Single‐Walled Carbon Nanotube Fluorescent Sensors,” Analytical Chemistry 94, no. 41 (2022): 14223–14231, 10.1021/acs.analchem.2c02471. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47. Kruss S., Landry M. P., Vander Ende E., et al., “Neurotransmitter Detection Using Corona Phase Molecular Recognition on Fluorescent Single‐Walled Carbon Nanotube Sensors,” Journal of the American Chemical Society 136, no. 2 (2014): 713–724, 10.1021/ja410433b. [DOI] [PubMed] [Google Scholar]
  • 48. Kelich P., Jeong S., Navarro N., et al., “Discovery of DNA–Carbon Nanotube Sensors for Serotonin with Machine Learning and Near‐infrared Fluorescence Spectroscopy,” ACS Nano 16, no. 1 (2022): 736–745, 10.1021/acsnano.1c08271. [DOI] [PubMed] [Google Scholar]
  • 49. Safaee M. M., Gravely M., and Wearable R. D. A., “A Wearable Optical Microfibrous Biomaterial with Encapsulated Nanosensors Enables Wireless Monitoring of Oxidative Stress,” Advanced Functional Materials 31, no. 13 (2021): 2006254, 10.1002/adfm.202006254. [DOI] [Google Scholar]
  • 50. Yoon M., Lee Y., Lee S., et al., “A nIR Fluorescent Single Walled Carbon Nanotube Sensor for Broad‐spectrum Diagnostics,” Sensors & Diagnostics 3, no. 2 (2024): 203–217, 10.1039/D3SD00257H. [DOI] [Google Scholar]
  • 51. Jiménez D. M., Isasti I., López‐Moreno A., and Pérez E. M., “Chemistry, Chirality, and Complexity as Concepts in Single‐Walled Carbon Nanotube Research,” (2025), 19085–19107, 10.1021/acsanm.5c02709. [DOI]
  • 52. Ehrlich R., Hendler‐Neumark A., Wulf V., Amir D., and Bisker G., “Optical Nanosensors for Real‐Time Feedback on Insulin Secretion by β‐Cells,” Small 17, no. 30 (2021): 2101660, 10.1002/smll.202101660. [DOI] [PubMed] [Google Scholar]
  • 53. Metternich J. T., Wartmann J. A. C., Sistemich L., Nißler R., Herbertz S., and Kruss S., “Near‐Infrared Fluorescent Biosensors Based on Covalent DNA Anchors,” Journal of the American Chemical Society 145, no. 27 (2023): 14776–14783, 10.1021/jacs.3c03336. [DOI] [PubMed] [Google Scholar]
  • 54. Hendler‐Neumark A. and Bisker G., “Fluorescent Single‐walled Carbon Nanotubes for Protein Detection,” Sens Switz 19, no. 24 (2019): 5403, 10.3390/s19245403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55. Pinals R. L., Ledesma F., Yang D., et al., “Rapid SARS‐CoV‐2 Spike Protein Detection by Carbon Nanotube‐Based Near‐Infrared Nanosensors,” Nano Letters 21, no. 5 (2021): 2272–2280, 10.1021/acs.nanolett.1c00118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56. Basu S., Hendler‐Neumark A., and Bisker G., “Rationally Designed Functionalization of Single‐Walled Carbon Nanotubes for Real‐Time Monitoring of Cholinesterase Activity and Inhibition in Plasma,” Small 20, no. 24 (2024): 1613–6810, 10.1002/smll.202309481. [DOI] [PubMed] [Google Scholar]
  • 57. Kallmyer N. E., Musielewicz J., Sutter J., and Reuel N. F., “Substrate‐Wrapped, Single‐Walled Carbon Nanotube Probes for Hydrolytic Enzyme Characterization,” Analytical Chemistry 90, no. 8 (2018): 5209–5216, 10.1021/acs.analchem.7b05444. [DOI] [PubMed] [Google Scholar]
  • 58. Yaari Z., Cheung J. M., Baker H. A., et al., “Nanoreporter of an Enzymatic Suicide Inactivation Pathway,” Nano Letters 20, no. 11 (2020): 7819–7827, 10.1021/acs.nanolett.0c01858. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59. Gerstman E., Hendler‐Neumark A., Wulf V., and Bisker G., “Monitoring the Formation of Fibrin Clots as Part of the Coagulation Cascade Using Fluorescent Single‐Walled Carbon Nanotubes,” ACS Applied Materials & Interfaces 15, no. 18 (2023): 21866–21876, 10.1021/acsami.3c00828. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60. Jeong S., Yang D., Beyene A. G., et al., “High‐throughput Evolution of near‐infrared Serotonin Nanosensors,” Science Advances 5 (2019): 3771–3789, https://www.science.org. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61. Beyene A. G., Alizadehmojarad A. A., Dorlhiac G., et al., “Ultralarge Modulation of Fluorescence by Neuromodulators in Carbon Nanotubes Functionalized with Self‐Assembled Oligonucleotide Rings,” Nano Letters 18, no. 11 (2018): 6995–7003, 10.1021/acs.nanolett.8b02937. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62. Dinarvand M., Neubert E., Meyer D., et al., “Near‐Infrared Imaging of Serotonin Release from Cells with Fluorescent Nanosensors,” Nano Letters 19, no. 9 (2019): 6604–6611, 10.1021/acs.nanolett.9b02865. [DOI] [PubMed] [Google Scholar]
  • 63. Kelich P., Adams J., Jeong S., Navarro N., Landry M. P., and Vukovic L., “Predicting Serotonin Detection with DNA‐Carbon Nanotube Sensors across Multiple Spectral Wavelengths,” Journal of Chemical Information and Modeling 64, no. 10 (2024): 3992–4001, 10.1021/acs.jcim.4c00021. [DOI] [PubMed] [Google Scholar]
  • 64. Galonska P., Mohr J. M., Schrage C. A., Schnitzler L., and Kruss S., “Guanine Quantum Defects in Carbon Nanotubes for Biosensing,” The Journal of Physical Chemistry Letters 14, no. 14 (2023): 3483–3490, 10.1021/acs.jpclett.3c00358. [DOI] [PubMed] [Google Scholar]
  • 65. Yin T., Zhao Y., Zhang J., et al., “Ultrasensitive and Selective Detection of Dopamine through Substituent‐Regulated Evolution of Quantum Defects,” ACS Sensors 10, no. 6 (2025): 4687–4696, 10.1021/acssensors.5c01153. [DOI] [PubMed] [Google Scholar]
  • 66. Mun J., Navarro N., Jeong S., et al., “Near‐infrared Nanosensors Enable Optical Imaging of Oxytocin with Selectivity over Vasopressin in Acute Mouse Brain Slices,” Proceedings of the National Academy of Sciences 121, no. 26 (2024): 2314795121, 10.1073/pnas.2314795121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67. Boonyaves K., Ang M. C.‐Y., Park M., et al., “Near‐Infrared Fluorescent Carbon Nanotube Sensors for the Plant Hormone Family Gibberellins,” Nano Letters 23, no. 3 (2023): 916–924, 10.1021/acs.nanolett.2c04128. [DOI] [PubMed] [Google Scholar]
  • 68. Pan J., Li F., and Choi J. H., “Single‐walled Carbon Nanotubes as Optical Probes for Bio‐sensing and Imaging,” Journal of Materials Chemistry B 5, no. 32 (2017): 6511–6522, 10.1039/C7TB00748E. [DOI] [PubMed] [Google Scholar]
  • 69. Wu H., Nißler R., Morris V., et al., “Monitoring Plant Health with Near‐Infrared Fluorescent H2O2 Nanosensors,” Nano Letters 20, no. 4 (2020): 2432–2442, 10.1021/acs.nanolett.9b05159. [DOI] [PubMed] [Google Scholar]
  • 70. Boonyaves K., Ang M. C.‐Y., Park M., et al., “Near‐Infrared Fluorescent Carbon Nanotube Sensors for the Plant Hormone Family Gibberellins,” Nano Letters 23, no. 3 (2023): 916–924, 10.1021/acs.nanolett.2c04128. [DOI] [PubMed] [Google Scholar]
  • 71. Chen J., Li Y., Wu J., et al., “Ordered DNA‐Wrapped Single‐Chirality Carbon Nanotubes Enable an Unparalleled Sensing Platform for Copper Ion Detection,” ACS Nano 19, no. 31 (2025): 28743–28754, 10.1021/acsnano.5c08364. [DOI] [PubMed] [Google Scholar]
  • 72. Cho Y., Baek H., Koh D., et al., “Label‐free and Real‐time Monitoring of Photoaging with High Spatiotemporal Resolution Using an nIR Fluorescent Nanosensor Array,” Science Advances 11, no. 37 (2025): adt2296, 10.1126/sciadv.adt2296. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73. Beyene A. G., Delevich K., Del Bonis‐O'Donnell J. T., et al., “Imaging Striatal Dopamine Release Using a Nongenetically Encoded near Infrared Fluorescent Catecholamine Nanosensor,” Science Advances 5 (2019): eaaw3108, 10.1126/sciadv.aaw3108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74. Bulumulla C., Krasley A. T., Cristofori‐Armstrong B., et al., “Visualizing Synaptic Dopamine Efflux with a 2D Composite Nanofilm,” ELife 11 (2022): 78773, 10.7554/eLife.78773. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75. Elizarova S., Chouaib A. A., Shaib A., et al., “A Fluorescent Nanosensor Paint Detects Dopamine Release at Axonal Varicosities with High Spatiotemporal Resolution,” Proceedings of the National Academy of Sciences 119, no. 22 (2022): 2202842119, 10.1073/pnas.2202842119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76. Kruss S., Salem D. P., Vukovic L., et al., “High‐resolution Imaging of Cellular Dopamine Efflux Using a Fluorescent Nanosensor Array,” Proceedings of the National Academy of Sciences 114, no. 8 (2017): 1789–1794, 10.1073/pnas.1613541114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77. Lee N., Lee D., Lee J. H., et al., “Nanosensor‐based Imaging of Realtime Dopamine Release in Neurons Derived from iPSCs of Patients with Parkinson's Disease,” Materials Today Bio 31 (2025): 101485, 10.1016/j.mtbio.2025.101485. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78. Ma C., Mohr J. M., Lauer G., et al., “Ratiometric Imaging of Catecholamine Neurotransmitters with Nanosensors,” Nano Letters 24, no. 7 (2024): 2400–2407, 10.1021/acs.nanolett.3c05082. [DOI] [PubMed] [Google Scholar]
  • 79. Yang S. J., Del Bonis‐O'Donnell J. T., Beyene A. G., and Landry M. P., “Near‐infrared Catecholamine Nanosensors for High Spatiotemporal Dopamine Imaging,” Nature Protocols 16, no. 6 (2021): 3026–3048, 10.1038/s41596-021-00530-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80. Bulumulla C., Walpita D., Iyer N., et al., “Synaptic Specializations at Dopamine Release Sites Orchestrate Efficient and Precise Neuromodulatory Signaling,” Neuroscience Preprint posted online (2024), 10.1101/2024.09.16.613338. [DOI] [Google Scholar]
  • 81. Sharaga E., Hendler‐Neumark A., Kamber D., and Bisker G., “Spatiotemporal Tracking of Near‐Infrared Fluorescent Single‐Walled Carbon Nanotubes in C. Elegans Nematodes Confined in a Microfluidics Platform,” Advanced Materials Technologies 9, no. 5 (2024): 2301222, 10.1002/admt.202301222. [DOI] [Google Scholar]
  • 82. Basu S., Hendler‐Neumark A., and Bisker G., “Role of Oxygen Defects in Eliciting a Divergent Fluorescence Response of Single‐Walled Carbon Nanotubes to Dopamine and Serotonin,” ACS Nano 18, no. 50 (2024): 34134–34146, 10.1021/acsnano.4c10360. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83. Foo K. Y. and Hameed B. H., “Insights into the Modeling of Adsorption Isotherm Systems,” Chemical Engineering Journal 156, no. 1 (2010): 2–10, 10.1016/j.cej.2009.09.013. [DOI] [Google Scholar]
  • 84. Schindler S. and Bechtold T., “Mechanistic Insights into the Electrochemical Oxidation of Dopamine by Cyclic Voltammetry,” Journal of Electroanalytical Chemistry 836 (2019): 94–101, 10.1016/j.jelechem.2019.01.069. [DOI] [Google Scholar]
  • 85. Dingova D., Leroy J., Check A., Garaj V., Krejci E., and Hrabovska A., “Optimal Detection of Cholinesterase Activity in Biological Samples: Modifications to the Standard Ellman's Assay,” Analytical Biochemistry 462 (2014): 67–75, 10.1016/j.ab.2014.05.031. [DOI] [PubMed] [Google Scholar]
  • 86. Prajapati K. P., Mittal S., Ansari M., et al., “Structural Conversion of Serotonin into Amyloid‐Like Nanoassemblies Conceptualizes an Unexplored Neurotoxicity Risk,” ACS Nano 18, no. 50 (2024): 34044–34062, 10.1021/acsnano.4c09522. [DOI] [PubMed] [Google Scholar]
  • 87. Nakatsuka N., Hasani‐Sadrabadi M. M., Cheung K. M., et al., “Polyserotonin Nanoparticles as Multifunctional Materials for Biomedical Applications,” ACS Nano 12, no. 5 (2018): 4761–4774, 10.1021/acsnano.8b01470. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88. Gutierrez‐Osuna R., Nagle H. T., and Schiffman S. S., “Transient Response Analysis of an Electronic Nose Using Multi‐exponential Models,” Sensors and Actuators B: Chemical 61, no. 1 (1999): 170–182, 10.1016/S0925-4005(99)00290-7. [DOI] [Google Scholar]
  • 89. Rosenberg D. J., Cunningham F. J., Hubbard J. D., et al., “Mapping the Morphology of DNA on Carbon Nanotubes in Solution Using X‐ray Scattering Interferometry,” Journal of the American Chemical Society 146, no. 1 (2024): 386–398, 10.1021/jacs.3c09549. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90. Boghossian? A. A., Zhang? J., Barone P. W., et al., “Near‐Infrared Fluorescent Sensors Based on Single‐Walled Carbon Nanotubes for Life Sciences Applications,” Chemsuschem 4, no. 7 (2011): 848–863, 10.1002/cssc.201100070. [DOI] [PubMed] [Google Scholar]
  • 91. Hinkle K. R., “Molecular Dynamics Simulations Reveal Single‐stranded DNA (ssDNA) Forms Ordered Structures Upon Adsorbing onto Single‐walled Carbon Nanotubes (SWCNT),” Colloids and Surfaces B: Biointerfaces 212 (2022): 112343, 10.1016/j.colsurfb.2022.112343. [DOI] [PubMed] [Google Scholar]
  • 92. Ao G., Streit J. K., Fagan J. A., and Zheng M., “Differentiating Left‐ and Right‐Handed Carbon Nanotubes by DNA,” Journal of the American Chemical Society 138, no. 51 (2016): 16677–16685, 10.1021/jacs.6b09135. [DOI] [PubMed] [Google Scholar]
  • 93. Li Y., Wen Y., Beltrán L. C., et al., “Understanding DNA‐encoded Carbon Nanotube Sorting and Sensing via Sub‐nm‐resolution Structural Determination,” Science Advances 11 (2025): adt9844. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 94. Bishop C. M., in Pattern Recognition and Machine Learning. Information Science and Statistics (Springer, 2006), Ch2–ProbabilityDistributions. [Google Scholar]
  • 95. Cover T. M. and Thomas J. A., Elements of Information Theory, 2nd ed. (Wiley‐Interscience, 2006), Ch8–DifferentialEntropy, 10.1002/047174882X. [DOI] [Google Scholar]
  • 96. Tian C., Shin S., Cho Y., Song Y., and Cho S. Y., “High Spatiotemporal Precision Mapping of Optical Nanosensor Array Using Machine Learning,” ACS Sensors 9, no. 10 (2024): 5489–5499, 10.1021/acssensors.4c01763. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supporting File 1: smll73339‐sup‐0001‐SuppMat.pdf.

Supporting File 2: smll73339‐sup‐0002‐MovieS1.mp4.

Download video file (2.3MB, mp4)

Supporting File 3: smll73339‐sup‐0003‐MovieS2.mp4.

Download video file (7.1MB, mp4)

Supporting File 4: smll73339‐sup‐0004‐MovieS3.mp4.

Download video file (1.4MB, mp4)

Supporting File 5: smll73339‐sup‐0005‐MovieS4.mp4.

Download video file (2.3MB, mp4)

Supporting File 6: smll73339‐sup‐0006‐MovieS5.mp4.

Download video file (1.8MB, mp4)

Supporting File 7: smll73339‐sup‐0007‐MovieS6.mp4.

Download video file (2.7MB, mp4)

Supporting File 8: smll73339‐sup‐0008‐MovieS7.mp4.

Download video file (1.4MB, mp4)

Supporting File 9: smll73339‐sup‐0009‐MovieS8.mp4.

Download video file (1.1MB, mp4)

Supporting File 10: smll73339‐sup‐0010‐MovieS9.mp4.

Download video file (1.2MB, mp4)

Supporting File 11: smll73339‐sup‐0011‐MovieS10.mp4.

Download video file (1.2MB, mp4)

Supporting File 12: smll73339‐sup‐0012‐MovieS11.mp4.

Download video file (3.2MB, mp4)

Supporting File 13: smll73339‐sup‐0013‐MovieS12.mp4.

Download video file (1MB, mp4)

Supporting File 14: smll73339‐sup‐0014‐MovieS13.mp4.

Download video file (1.2MB, mp4)

Supporting File 15: smll73339‐sup‐0015‐MovieS14.mp4.

Download video file (1.2MB, mp4)

Supporting File 16: smll73339‐sup‐0016‐MovieS15.mp4.

Download video file (706.4KB, mp4)

Data Availability Statement

The data that support the findings of this study are available from the corresponding author upon reasonable request.


Articles from Small (Weinheim an Der Bergstrasse, Germany) are provided here courtesy of Wiley

RESOURCES